Oakworth Capital’s Bio-Techne TECH Stock Holding History

Oakworth Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.25K	Hold	74	–	–	﹤0.01%	778
2026 Q1	$3.87K	Hold	74	–	–	﹤0.01%	756
2025 Q4	$4.35K	Hold	74	–	–	﹤0.01%	748
2025 Q3	$4.12K	Hold	74	–	–	﹤0.01%	702
2025 Q2	$3.81K	Hold	74	–	–	﹤0.01%	543
2025 Q1	$4.34K	Hold	74	–	–	﹤0.01%	582
2024 Q4	$5.33K	Sell	74 -14	-16%	-$1.03K	﹤0.01%	545
2024 Q3	$7.03K	Hold	88	–	–	﹤0.01%	535
2024 Q2	$6.3K	Hold	88	–	–	﹤0.01%	539
2024 Q1	$6.19K	Hold	88	–	–	﹤0.01%	515
2023 Q4	$6.79K	Hold	88	–	–	﹤0.01%	515
2023 Q3	$5.99K	Hold	88	–	–	﹤0.01%	490
2023 Q2	$7.18K	Hold	88	–	–	﹤0.01%	511
2023 Q1	$6.53K	Hold	88	–	–	﹤0.01%	478
2022 Q4	$7.29K	Buy	+88	New	+$6.99K	﹤0.01%	453

Other funds holding TECH

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Oakworth Capital's TECH Position: Q2 2026 in Review

Oakworth Capital held its Bio-Techne (TECH) position steady in Q2 2026 at 74 shares worth $5.25K. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Oakworth Capital first reported a position in TECH in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.29K in Q4 2022. 186 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Oakworth Capital held 74 shares of Bio-Techne worth $5.25K as of Q2 2026.
Oakworth Capital left its Bio-Techne share count unchanged in Q2 2026.
Bio-Techne made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #778 holding.
Oakworth Capital first reported a position in Bio-Techne in Q4 2022 and has held it in 15 quarters since.
Oakworth Capital's Bio-Techne position peaked at $7.29K in Q4 2022.
186 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.